FACE PRESENTATION

This adverse event was reported 59 times

FACE PRESENTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALGLUCOSIDASE ALFA 1 0.0004
1 NABUMETONE 1 0.0002
2 CLADRIBINE 1 0.0001
3 PEGINTERFERON BETA-1A 1 0.0001
4 LABETALOL 1 0.0001
5 MECLIZINE HCL 12.5 MG 1 0.0001
6 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 2 0.0001
7 TIZANIDINE HYDROCHLORIDE 1 0.0001
8 MECLIZINE HYDROCHLORIDE 1 0.0001
9 PAROXETINE HYDROCHLORIDE 2 0.0000
See all drugs enriched for association with FACE PRESENTATION

FACE PRESENTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1 0.0003
1 Progesterone [EPC] 1 0.0000
2 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
3 Interferon beta [EPC] 5 0.0000
4 Expectorant [EPC] 3 0.0000
5 Anti-IgE [EPC] 1 0.0000
6 Purine Antimetabolite [EPC] 1 0.0000
7 Vitamin D [EPC] 3 0.0000
8 Vitamin B12 [EPC] 3 0.0000
9 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
See all drug classes enriched for association with FACE PRESENTATION